Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 42c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: IONS) | Delayed: 44.95 -0.33 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.28 | 52 Week High | $62.68 | |||
| Open | $45.37 | 52 Week Low | $19.59 | |||
| Day High | $45.46 | P/E | N/A | |||
| Day Low | $44.61 | EPS | $0.00 | |||
| Volume | 73,831 | |||||
